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ABSTRACT 
Objective: To determine the impact of HIV disease on immediate maternal and foetal 
outcomes at the Kenyatta National Hospital, Nairobi, Kenya 
Design: Prospective cohort study. 
Setting: Kenyatta National Hospital, Nairobi, Kenya, between September 2004 and 
April 2005. 
Subjects: Sixty eight mothers with advanced HIV disease (WHO clinical stage 3 and 
4) and 68 HIV negative pregnant mothers. 
Results: Mothers with advanced HIV disease were more likely to be anaemic (55% vs. 
16% p<0.001), to have sexually transmitted diseases (56% vs. 15%, p=0.004), to have 
chorioamnionitis (14.8% vs. 2%, p=0.004), to develop preterm premature rupture of 
membranes (31 % vs. 9%, p<0.001), to have puerperal pyrexia (16% vs. 2%, p=0.032) 
an to die (5% vs. 0.5%, p=0.028) compared to HIV negative mothers. The mean 
gestational age at deliver was lower in mothers with advanced HIV disease compared 
to the seronegative counterparts (73% vs. 32%, delivery<37 weeks, p<0.00l). Infants of 
mothers with advanced HIV disease compared to infants of seronegative mothers were 
more likely to be low birth weight infants (58% vs. 21%, p<0.00l), stillborn (4% vs. 
2%, p=0.308) and to have low Apgar scores (28% vs. 12%, Apgar score < 4 at 5 minutes 
p=0.02). Perinatal sepsis and perinatal deaths were more common in infants born to 
mothers with advanced HIV disease compared to infants born to HIV negative mothers 
(8 vs. 3, p=0.003 and 14 vs. 5, p=0.025 respectively). External congenital anomalies were 
similar in the two groups (5.9% vs. 5.9%). 
Conclusion: Pregnancies complicated by advanced HIV disease are more likely to have 
adverse outcomes, both maternal and foetal. Advanced HIV disease is associated with 
increased risk of both maternal and fetal mortality. HIV infected mothers should be 
counselled on the increased pregnancy risks associated with advanced disease. 
INTRODUCTION 
Pregnancy outcomes in mothers with HIV infection 
have been a subject of many studies both in the 
developed and the developing world. Differences 
exist in results in studies on pregnancy outcomes in 
HIV infected women from Africa compared to those 
from Europe and the USA (1). Whereas most studies in 
Africa have shown increased adverse outcomes, most 
Western studies have shown little or no demonstrable 
impact of HIV infection on pregnancy and on maternal 
and neonatal outcomes (1). 
 Neonatal morbidity such as prematurity, 
low birth weight, low Apgar scores, stillbirths, 
neonatal sepsis, perinatal and neonatal mortality 
and congenital anomalies have been the focus of the 
comparison studies between HIV seropositive and 
seronegative mothers. Maternal morbidity including 
anaemia, premature rupture of membranes, sexually 
transmitted disease, chorioamnionitis, puerperal 
pyrexia, postpartum haemorrhage, length of hospital 
stay and maternal mortality have also been studied 
extensively. All these factors have a significant 
bearing on child survival and maternal well-being. 
The Western studies which have focused on pregnant 
mothers with HIV disease are small in number and 
have included small number of pregnant mothers. 
They may hence lack statistical power to detect a 
true difference both in foetal and maternal outcome 
characteristics (1). Most African studies reported 
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increased adverse outcomes. However, a few have 
shown no significant difference in pregnancy outcome 
HIV infected mothers and their healthy HIV negative 
controls. None of these studies focused, exclusively on 
mothers with advanced HIV disease where adverse 
impact is likely to be maximal. 
 This study focused on pregnant mothers with 
advanced HIV disease (WHO clinical stage 3 and 4). 
The objective of the study was to determine the impact 
of advanced HIV disease on immediate maternal and 
foetal outcomes. It was a prospective cohort study 
conducted at the Kenyatta National Hospital from 
September 2004 to April 2005. 
MATERIALS AND METHODS 
Mothers with advanced HIV disease were recruited 
from the antenatal wards of Kenyatta National 
Hospital by the principal investigator assisted by 
two nurses. Information regarding the research was 
given to the participants and those that agreed to 
participate signed on informed consent form. 
 Once a mother with advanced HIV disease 
was identified, a control matched for age ±5 years 
and gestation by dates ±4 weeks was identified and 
interviewed from the antenatal clinic. The first part of 
the structured questionnaire was then administered. 
Mothers with advanced HIV disease and those who 
were HIV negative were followed up by the principal 
investigator and the nurses until delivery or until 
the final outcome of the pregnancy was known. The 
second part of the structured questionnaire was 
filled and completed one week after delivery when 
the final status of the mother and the infant was 
determined. 
 The raw data from the questionnaires were then 
verified, coded and entered into the computer using 
Epi Info version 6 and further analysis was done using 
the SPSS programme. Two by two tables were used to 
test for associations and odds ratio calculations were 
performed. Chi-squared test was used for proportional 
variables and the t-test for continuous variables. 
A P-value of 0.05 or less was taken to be significant. 
RESULTS 
Mothers who met the study criteria were interviewed. 
A total of 177 mothers were invited to participate but 
17 mothers declined to participate citing personal 
reasons and lack of direct benefit of the study to them. 
The women who agreed to participate were followed 
up over a period of 32 weeks. 
 Twenty three mothers were lost to follow up. One 
hundred and thirty eight mothers were seen during 
delivery and 137 mothers one week after delivery. 
One HIV negative mother absconded before the end 
of the follow up period while the delivery notes of 
one infant born to a HIV negative mother got lost. 
Analysis was hence done on a total of 136 mothers, 
68 of them HIV negative and 68 with advanced HIV 
disease.
 Table 1 shows the sociodemographic and 
antenatal characteristics of the study participants. 
Mothers with advanced HIV disease were more 
likely to be older than the HIV negative mothers 
(27 years vs. 24 years p=0.009). This difference was 
significant. There was no difference in the marital 
status between the two groups. HIV negative mothers 
were more educated than mothers with advanced HIV 
disease and this difference was significant (p=0.004). 
Primigravidas were more among the HIV negative 
mothers compared to mothers with advanced HIV 
disease (p=0.001). Mothers with advanced HIV 
disease were more likely to have had previous 
abortions compared to the HIV negative mothers 
and this difference achieved statistical significance 
(p=0.008). There was no difference in the VDRL status 
in the two groups but the incidence of candidiasis and 
trichomoniasis was higher in mothers with advanced 
HIV disease (41% vs. 12%, p<0.00l, RR=3.5). Mothers 
with advanced HIV disease were more likely to be 
anaemic compared to the HIV negative mothers 
(55% vs. 16%, p<0.00l). The study participants were 
enrolled at more or less the same gestation. 
 More seronegative mothers underwent induction 
of labour compared to mothers with advanced HIV 
disease (16% vs. 13%, p=0.6). In total there were more 
Caesarean sections done in the seronegative group 
compared to the advanced HIV group (41% vs. 13% 
p<0.00l, RR=0.3 95% CI 0.2-0.6). No operative vaginal 
delivery was performed in the advanced HIV group 
while there were three vacuum deliveries in the HIV 
negative group. 
 Mothers with advanced HIV disease were 
more likely to have preterm premature rupture of 
membranes compared to the HIV negative mothers 
(10% vs. 6% p=0.5). Women with advanced HIV 
disease were more prone to preterm premature 
rupture of membranes and this difference achieved 
statistical significance (31 % vs. 10% p=0.003, RR 3, 
95% CI 1.4-6.6). Chorioamnionitis was found to occur 
more in mothers with advanced HIV disease (10% 
vs. 6% p=0.5) 
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Figure 1 
Enrollment and follow-up of participants 
 Advanced HIV  HIV negative 
Invited to participate  85  92 
Agreed to participate  76  84
Seen during delivery  68  70
Seen one week after delivery  68  69
Lost to follow-up 8  15  
Table 1 
Study population characteristics 
Characteristic             Women with advanced    HIV negative P-value Relative
          HIV disease (n=68)       women (n=68)     risk/95% CI
  No. (%) No.  (%)   
Above primary education 6 9 19 28 0.004 0.3 (0.1-0.7)
Married 53 78 52 78 1 1 (0.8-1.2)
Unemployed 44 65 42 63 0.8 1 (0.8-1.3)
Primigravida 9 14 34 50 <0.001 0.3 (0.1-0.5)
Had previous abortion 13 22 4 6 0.008  3.7 (1.3-10.7)
Haemoglobin < 10g/dl 37 55 11 16 <0.001 3.4 (1.9-6.0)
VDRL positive 2 3 1  1 0.0308 0.8 (1.2-1.7)
Trichomoniasis or 28 41 8 12 <0.001 3.5 (1.7-7.1) 
candidiasis   
Mean age (years) 27.03   24.41   0.009 0.9 (0.8-1) 
Mean gestation at      
enrollment (weeks) 31.1   31.2   0.811 1.0 (0.9-1.1) 
Table 2 
Maternal pregnancy outcomes 
            Advanced HIV        HIV negative  P-value  Relative 
Characteristic          (n=68)            (n=68)    risk/95% CI 
 No.  (%)  No.  (%)   
Postpartum pyrexia  15  23  6  9  0.03  2.5 (1.0-6.0) 
temp >38°C        
Hospitalisation > week 1  23  44  11  27  0.1  1.6 (0.9-2.9) 
Maternal deaths 6  9  0  0  0.028  NIL 
Caesarean section delivery  9  13  28  41  <0.001  0.3 (0.2-0.6) 
Labour induction  7  13  10  16  0.6  0.8 (0.3-1.9)
Operative vaginal delivery  0  0  3  4.5  0.2  NIL 
Preterm PROM  7  10  4  6  0.5  17 (0.5-5.7)
Term PROM  21  31  7  10  0.003  3 (1.4-6.6) 
Chorioamnionitis  7  10  4  6  0.5  1.7 (0.5-5.7)
Meconium staining in liquor  22  35  14  20  0.07  1.7 (0.9-3.0) 
Hypertensive disease  9  14  8  12  0.7  1.0(0.9-1.1) 
DBP>90mmHg 
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Table 3 
Foetal pregnancy outcomes 
Characteristic          Advanced HIV          HIV negative  P-value  Relative 
           (n=68)         (n=68)    risk 95% CI 
 No.  (%)  No.  (%)   
Gestation at  48  73  22  22  <0.001  2.2 (1.5-3.3) 
delivery <37 weeks  
Low birth weight  38  58  14  21  <0.001  2.8 (1.7-4.7) 
<2500gm        
Apgar score <4 at 5  18  27  8  12  0.02  2.3 (1.1-5.0) 
minutes        
Congenital anomalies 4  6  4  6  1  NIL 
 Neonatal sepsis  8  12  3  4  0.1  2.7 (0.7-9.6)
Neonatal deaths  13  22  3  6  0.03  3.5 (1.0-11.4)  
 There was no statistical difference in hypertensive 
disease and hospital stay for more than a week 
between the two groups. There were six maternal 
deaths in the advanced HIV group and no maternal 
deaths in the HIV seronegative group. This difference 
was statistically significant (p=0.028). Three mothers 
passed away due to complications of pulmonary 
tuberculosis, two due to bacterial meningitis and one 
due to presumptive pneumocystis carinii pneumonia 
(PPCP). 
 Mothers with advanced HIV disease tended to 
deliver earlier compared to HIV negative mothers 
(73% vs. 32% p<0.00l RR=2.2, 95% CI 1.5-3.3). The 
mean gestation at delivery was 35 weeks for mothers 
with advanced HIV disease compared to 38 weeks for 
HIV negative mothers (p<0.00l). Infants of mothers 
with advanced HIV disease compared to infants of 
HIV negative mothers were more likely to be low 
birth weight infants 38 (56%) vs. 14 (21%) birth weight 
<2500gm p<0.00l). Infants born to mothers with 
advanced HIV disease tended to have lower Apgar 
scores and this was significant for Apgar score less 
than four at five minutes (18 vs. 8, p=0.02). There 
was no difference in the rate of congenital anomalies 
between the two groups (5.9% vs. 5.9%). Infants 
of mothers with advanced HIV, disease suffered 
significant neonatal sepsis (12% vs. 4% p=0.l) and 
early neonatal deaths (22% vs. 6% p=0.03 RR=3.5, 
95% CI 1.0-11.4) compared to infants born to mothers 
who were HIV negative. 
DISCUSSION 
This was a prospective cohort study whose aim was 
to document the immediate impact of advanced HIV 
disease on pregnancy. Overall, our findings suggest 
that advanced HIV disease is associated with poor 
pregnancy outcome both foetal and maternal. We 
observed that mothers with advanced HIV disease 
booked with lower haemoglobin levels and this 
anaemic condition placed then at a higher risk 
of mortality and morbidity during the antenatal, 
perinatal and puerperium. Sukwa et al (3) in Ndola 
Zambia had similar findings. In our study, sexually 
transmitted infections occurred more significantly 
in mothers with advanced HIV disease. This is 
comparable to what Temmermann and colleagues 
(4) found in the study of maternal HIV infection 
and pregnancy outcome. Burns et al (5) found that 
vaginal colonisation with candidiasis occurred 
frequently in pregnant mothers infected with HIV 
virus. This collective data strongly suggests that 
HIV infected pregnant women are at an increased of 
sexually transmitted disease compared to uninfected 
women. 
 Syphilis is more common in HIV positive women 
in Africa with an incidence of up to 33% being reported 
(6). In our study, an increased risk among mothers 
with advanced HIV disease was found though the 
difference was not significant. Temmermann and 
colleagues (4) in Langata, Nairobi, found the incidence 
of syphilis in HIV positive women to be 3.2% and also 
reported that the HIV positive mother was two and 
a half times more likely to have a positive VDRL test 
(4). Guay et al  (7) in Uganda found that HIV positive 
mothers were more likely to have been tested for 
syphilis (22% vs. 14.5%). Syphilis is a major cause 
of perinatal and infant mortality and morbidity and 
mothers with advanced HIV disease appear to be 
affected more by the disease. 
 Term and preterm premature rupture of 
membranes occurred frequently among mothers with 
advanced HIV disease. This has adverse implications 
for mother to child transmission of the virus and 
foetal survival because of increased incidence of 
prematurity. Premature rupture of membranes could 
also have been a contributing factor of increased 
incidence of chorioamnionitis among mothers with 
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advanced disease. Omondi et al (8) also reported 
that HIV positive mothers tended to have premature 
rupture of membranes (14.9% vs. 5%). 
 Our study suggests that advanced HIV disease 
predisposes to prematurity. More than half of the 
mothers with advanced HIV disease delivered at less 
than 37 completed weeks. This finding is in agreement 
with reports from a larger prospective cohort study 
conducted in Dar es Salaam, Tanzania (9). In the 
latter study, prematurity was significantly observed 
among symptomatic HIV-infected women when 
compared with HIV -uninfected women. Prematurity 
is associated with high neonatal mortality and 
morbidity in our set-up and advanced HIV disease 
will increase the burden of neonatal care. 
 In a study by Nyongo et al (10), moderate to severe 
chorioamnionitis was found in 20% of preterm and 
8% of term pregnancies. Within preterm deliveries, 
the placentas showed chorioamnionitis with 37% 
of cases where the woman was HIV positive and 
18% of matched seronegative cases. In our study 
10% of mothers with advanced HIV disease had 
chorioamnionitis compared to 6% in the HIV negative 
group. This did not achieve statistical significance 
(p=0.5), though it appears that mothers with advanced 
HIV disease have a higher risk of chorioamnionitis 
and its associated complications compared to the HIV 
negative mothers. More mothers with advanced HIV 
disease suffered post partum pyrexia (Temp >38°C) 
compared to their seronegative counterparts (p=0.03). 
This could possibly be attributed to the higher risk 
of chorioamnionitis in the same mothers. 
 Our study recorded six maternal deaths in the 
advanced HIV group and no maternal deaths in the 
HIV negative group. This difference was statistically 
significant (p=0.028). This finding is in agreement with 
some Western studies which also recorded higher 
maternal mortality in pregnant mothers with AIDS 
(11,12). In our study, three mothers passed away from 
complications of pulmonary tuberculosis, two from 
bacterial meningitis and one due to presumptive 
pneumocystis carinii pneumonia. 
 Many studies in developed countries have shown 
little difference in birth weights of babies born to 
HIV positive mothers compared to infants born to 
uninfected mothers. However, Minkoff et al (13) found 
high rates of low birth weight in mothers who were 
HIV infected. Low birth weight is mostly reported in 
sub-Saharan African countries and especially among 
symptomatic mothers or mothers with AIDS. In this 
study, the difference in birth weight was significant, 
with mothers with advanced HIV disease giving 
birth to more low birth weight babies compared to 
HIV uninfected mothers. These findings are similar 
to those of Temmermann et al (14) in Nairobi, Guay 
et al (7) in Uganda, Chamiso (15) in Ethiopia, Jenny et 
al (9) in Tanzania and Taha (16) in Malawi. However, 
Lepage (2) in Rwanda found difference in birth 
weights between HIV positive and HIV negative 
mothers. 
 The five minute Apgar score was poorer in infants 
born to mothers with advanced HIV disease compared 
to infants of HIV uninfected mothers. Similar findings 
were reported by Guay et al (7) in Uganda and Chamiso 
(15) in Ethiopia, however Temmermann et al (17) did 
not find any significant difference in Apgar scores 
between infants of seropositive and seronegative 
mothers. 
 Though there were no significant differences in 
occurrence of congenial anomalies between the two 
groups, neonatal sepsis and early neonatal deaths 
occurred frequently in infants born to mothers with 
advanced HIV disease. It is possible that preterm 
delivery, chorioamnionitis with amniotic fluid 
infection could account for higher rates of neonatal 
deaths and neonatal sepsis seen in infants born to 
mothers with advanced HIV disease. This association 
was recently reported in one large controlled study, 
where pregnancies from 457 seropositive women 
were compared with those of 615 seronegative 
women matched for age and parity. Not only was 
chorioamnionitis more common in the former group, 
but also babies, were more frequently premature and 
the neonatal death rate was increased (18). 
 A higher proportion of HIV infected pregnant 
women in sub-Saharan Africa are likely to consist 
of those who are in an advanced clinical and 
immunological stage of the disease and many of them 
enter pregnancy when they are immunosuppressed. 
This is compounded by a higher prevalence of 
malnutrition, opportunistic infections and poor 
access to treatment. These factors in various degrees 
of combination have adverse impact on pregnancy 
outcome regardless of the mothers’ HIV status. 
 Overall, our data show that pregnancies 
complicated by advanced HIV disease have 
significant increased risk of maternal and foetal 
mortality and morbidity. The biological mechanisms 
of HIV as a cause of adverse pregnancy outcome 
are not yet fully understood but it is clear from 
many studies that statistical detectable biological 
effects upon pregnancy occurs in mothers with HIV 
infection and more so, those who are in advanced 
stage of the disease. Larger on-going natural 
history studies of HIV infected cohorts of pregnant 
women, such as the National Institutes of Health 
(NIH) sponsored Women and Infants Transmission 
Study are hoped to provide more definitive answers 
regarding the relationship between HIV infection 
and pregnancy (19). 
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